Page last updated: 2024-11-05

trihexyphenidyl and Pneumonia

trihexyphenidyl has been researched along with Pneumonia in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Pneumonia: Infection of the lung often accompanied by inflammation.

Research Excerpts

ExcerptRelevanceReference
"However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported."5.56Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report. ( Chen, Y; Feng, C; Kang, Y; Liu, F; Ma, W; Xu, G; Zhao, J, 2020)
"However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported."1.56Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report. ( Chen, Y; Feng, C; Kang, Y; Liu, F; Ma, W; Xu, G; Zhao, J, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhao, J1
Xu, G1
Feng, C1
Chen, Y1
Kang, Y1
Liu, F1
Ma, W1

Other Studies

1 other study available for trihexyphenidyl and Pneumonia

ArticleYear
Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report.
    Medicine, 2020, Volume: 99, Issue:20

    Topics: Antiparkinson Agents; Humans; Hyponatremia; Male; Malignant Hyperthermia; Middle Aged; Parkinson Dis

2020